Ventilator Associated Pneumonia Clinical Trial
Official title:
A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia: a Randomized Prospective Study
Objective of this study was to determine incidence, risk factors, etiological
micro-organisms and their antimicrobial susceptibility pattern and outcome of VAP; and to
study effect of ranitidine vs. sucralfate, used for stress ulcer prophylaxis, on gastric
colonization and on occurrence of VAP.
Methods: Design: Prospective randomized study. Setting: ICUs of Medicine Department and
Anesthesiology Department, Maulana Azad Medical College and Lok Nayak Hospital, University
of Delhi, New Delhi. Patients: 50 patients of age more than 12 years, who had been on
ventilator for more than 48 hrs. Intervention: Endotracheal Aspirate and blood sample of all
patients were cultured to determine micro-organisms causing VAP and their antimicrobial
susceptibility pattern. Patients were divided into 2 groups on random basis. The first group
was given ranitidine for stress ulcer prophylaxis while the second was given sucralfate.
Thereafter, difference in gastric colonization (on basis of quantitative culture of
nasogastric aspirate) and on occurrence of VAP in both the groups was compared.
Study Hypothesis: Study was designed to create data about Ventilator associated pneumonia in
developing countries like India. This data is crucial for providing information for deciding
future guidelines for treatment of and prevention of Ventilator associated pneumonia.
Further to test the hypothesis that H2 blockers, by virtue of raising gastric Ph, increase
gastric colonization by pathogenic organism and increase incidence of Ventilator associated
pneumonia; patients were divided into two groups on random basis, as described above.
Study population: Fifty patients of either sex admitted to Medical Intensive Care Unit and
Intensive Care Unit of Anaesthesiology department of Maulana Azad Medical College and Lok
Nayak Hospital, New Delhi( a 2000 bedded, tertiary care centre), fulfilling the criteria
were enrolled and prospectively followed up until one week after discharge from intensive
care unit or till death.
Methodology: Ventilator associated pneumonia was diagnosed when new and persistent pulmonary
infiltrates (not otherwise explained) appeared on chest radiograph after 48 hours of
ventilation and any two of the following three criteria were fulfilled:
1. Temperature of more than 38oC or less than 35oC.
2. Leukocytosis ≥16,000 or leukopenia ≤ 3,000.
3. Purulent endotracheal aspirate and/or positive endotracheal aspirate culture. Protocol
of study: All patients were ventilated by orotracheal or tracheostomy tube, which was
changed only if, blocked or displaced. Patients were ventilated in supine position with
frequent changing to right lateral and left lateral positions and nasogastric tube was
put in all patients. No prophylactic topical oropharyngeal antibiotic and selective gut
decontamination was done in any of the patients. Base line complete blood count was
done in all patients at time of intubation. Subsequent counts were done when pneumonia
was suspected by onset of fever, new chest signs, worsening of ventilatory requirement
and radiologically new infiltrates. Baseline chest X-ray and endotracheal aspirate
culture was done at intubation and at 48 hours of ventilation and subsequently done at
suspicion of pneumonia or any other pulmonary complications, 48 hours after pneumonia
has been detected, routinely once a week if no pneumonia is detected. Nasogastric
aspirate culture was done on 3rd and 7th day of intubation and every week thereafter.
Gastric colonization was diagnosed if more than 103 colony-forming units/ml were found.
Clinical examination for pneumonia and chest radiographs after one week of extubation
were done on follow up.
Method of collection of samples: Endotracheal aspirate was collected with mucus trap under
all aseptic precautions. Nasogastric (NG) aspirate was collected from indwelling NG tubes.
After removing the initial 5 ml, the next 10 ml of fluid in the tube was aspirated into a
sterile syringe and immediately transported to the laboratory for processing.
Culture method: A Semi quantitative culture of the endotracheal aspirate and nasogastric
aspirate was done [6]. A Measured amount of aspirate was plated on blood agar and Mac-Conkey
medium and a colony count was done after incubation. A sample of blood was collected in
glucose broth and after overnight incubation, subcultures were done on blood agar and
Mac-Conkey agar. Colony characteristics were observed and identification was done in
accordance with standard recommendations. Susceptibility of the organisms isolated from
endotracheal aspirate was done by disc diffusion technique employing the Stokes method.
Grouping of patients: Patients enrolled into study were divided randomly into two groups on
random basis. One group was given Ranitidine (H2 blocker) 50 mg I.V. every 8 hourly as
stress ulcer prophylaxis while the other group recieved Sucralfate (surface active agent) 1g
6 hourly via nasogastric tube. Occurrence of VAP in each group was recorded and compared.
Gastric colonization in each group was monitored by semi-quantitative culture.
Risk factors studied were age, sex, underlying disease, prior respiratory disease including
Chronic obstructive airway disease (COPD), prior hospitalization, duration of intubation,
numbers of intubations, prior antibiotic therapy etc. Other parameters noted were indication
of mechanical ventilation and outcome of patients with VAP Statistical methods: Incidence,
risk factors, outcome and antimicrobial susceptibility were calculated in absolute numbers
and percentages. Comparison of effect of ranitidine vs. sucralfate on occurrence of VAP was
done by chi square test and effect of ranitidine vs. sucralfate on gastric colonization was
calculated in absolute numbers and percentages and compared. All statistics were calculated
using SPSS software. P value <0.05 was considered significant.
RISK FACTORS studied include age, sex, underlying disease, prior COPD, prior
hospitalization, duration of intubation, no. of intubation. Longer duration of dependence on
ventilator increased the risk for VAP significantly (p value 0.001). Similarly, reintubation
also emerged as clear predisposing factor for VAP (See table 1).
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03937947 -
Traumatic Brain Injury Associated Radiological DVT Incidence and Significance Study
|
||
Not yet recruiting |
NCT04057625 -
Transthoracic Ultrasound in the Diagnosis and Follow-up of Ventilator Associated Pneumonia
|
N/A | |
Not yet recruiting |
NCT03267693 -
Gastrointestinal Complications in Association With Oropharyngeal and Respiratory Infections in Mechanical Ventilation
|
N/A | |
Completed |
NCT02078999 -
Biomarkers in Patients Undergoing Mechanical Ventilation
|
N/A | |
Completed |
NCT00726167 -
Serum Procalcitonin Study in the Management of Ventilated Patients
|
N/A | |
Recruiting |
NCT05124977 -
Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care
|
N/A | |
Recruiting |
NCT05331885 -
A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2
|
Phase 3 | |
Completed |
NCT05517759 -
Application of VAP Bundle Among ICU Nurses
|
||
Active, not recruiting |
NCT04488510 -
Pathogens Involved in Secondary Infections During Severe Forms of Covid-19 Pneumonia:
|
||
Completed |
NCT03917888 -
Clinical Impact of Lung Ultrasound Monitoring for Diagnosis of VAP
|
N/A | |
Not yet recruiting |
NCT06066489 -
Effect of Educational Program About Preventive Care Bundle for Prevention of Ventilator Associated Pneumonia Among Newborns
|
N/A | |
Completed |
NCT02096328 -
Pharmacokinetics, Safety and Efficacy of POL7080 in Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia
|
Phase 2 | |
Terminated |
NCT00771719 -
Open Label Pharmacokinetic in Adult Patients With Ventilator-Associated Pneumonia
|
Phase 1 | |
Recruiting |
NCT05696093 -
Efficacy of Cotrimoxazole as a De-escalation Treatment of Ventilator-Associated Pneumonia in Intensive Care Unit
|
Phase 3 | |
Recruiting |
NCT05354778 -
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
|
N/A | |
Not yet recruiting |
NCT06059040 -
Effect of Eliminating Gastric Residual Volume Monitoring on Ventilator Associated Events
|
N/A | |
Completed |
NCT04563104 -
Lung Ultrasound in Procalcitonin- Guided Antibiotic Discontinuation in Ventilator Associated Pneumonia
|
||
Terminated |
NCT01975350 -
Efficacy Study of Colistimethate Sodium Inhalation in Patients With Ventilator-associated Pneumonia
|
||
Recruiting |
NCT06000761 -
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
|
N/A | |
Not yet recruiting |
NCT03294837 -
Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit
|
N/A |